Voyageur Minerals Ltd. announced that it has applied for its bulk sample permit from the British Columbia Ministry of Mines. The 10,000 tonne bulk sample will be used for a major part of Voyageur’s feasibility study.  The barite recovered from the bulk sample will be allocated to Voyageur’s barium contrast suspension manufacturing joint venture company, ImagingX Pharmaceuticals Inc. (“ImagingX”). Voyageur, through ImagingX, is formulating, naming, and preparing applications for permitting for that company’s first sales of high purity barite products into the pharmaceutical barium contrast suspension market. This milestone will provide Voyageur with a revenue stream from its 100% owned Frances Creek barium project.  The bulk sample will form a basis to: complete the feasibility study; move the Frances Creek asset forward as a full production quarry; establish an asset value on the Frances Creek deposit based on revenue generated by ImagingX; to establish reserves. Voyageur has been successfully implementing its strategy to establish value for it’s Frances Creek barite deposit by creating a JV with established pharmaceutical manufacturing company Chief Medical Supply Ltd., which will allow Voyageur to sell its barite at one of the highest price points in the barium sulfate market.